Enovis Corp Research and Development Expense
Enovis Corp (ENOV) reported Research and Development Expense of $31.69 million for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- Enovis Corp research and development expense for the quarter ending 2026-07-03 was $31.69M, a 3.21% increase year-over-year.
- Enovis Corp research and development expense for the quarter ending 2026-04-03 was $31.53M, a 10.53% increase year-over-year.
- Enovis Corp research and development expense for the quarter ending 2025-12-31 was $31.36M, a 30.95% increase year-over-year.
- Enovis Corp research and development expense for the quarter ending 2025-10-03 was $29.74M, a 45.13% increase year-over-year.
- Enovis Corp research and development expense for fiscal 2025 was $120.33M, a 31.80% increase from fiscal 2024.
- Enovis Corp research and development expense for fiscal 2024 was $91.30M, a 21.20% increase from fiscal 2023.
- Enovis Corp research and development expense for fiscal 2023 was $75.33M, a 23.84% increase from fiscal 2022.
- Enovis Corp research and development expense for fiscal 2022 was $60.83M, a 23.90% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-07-03 | $31.69M 10-Q · filed 2026-08-06 | $63.22M 10-Q · filed 2026-08-06 | $94.58M derived: sum of 3 quarters · filed 2026-08-06 | $124.32M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-04-03 | $31.53M 10-Q · filed 2026-05-07 | $62.90M derived: sum of 2 quarters · filed 2026-05-07 | $92.64M derived: sum of 3 quarters · filed 2026-05-07 | $123.34M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $31.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $61.10M derived: sum of 2 quarters · filed 2026-02-26 | $91.80M derived: sum of 3 quarters · filed 2026-08-06 | $120.33M 10-K · filed 2026-02-26 | |||
| 2025-10-03 | $29.74M 10-Q · filed 2025-11-06 | $60.44M derived: sum of 2 quarters · filed 2026-08-06 | $88.97M 10-Q · filed 2025-11-06 | $112.92M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-07-04 | $30.70M 10-Q · filed 2026-08-06 | $59.23M 10-Q · filed 2026-08-06 | $83.18M derived: sum of 3 quarters · filed 2026-08-06 | $103.67M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-04-04 | $28.53M 10-Q · filed 2026-05-07 | $52.48M derived: sum of 2 quarters · filed 2026-05-07 | $72.97M derived: sum of 3 quarters · filed 2026-05-07 | $96.45M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $23.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $44.44M derived: sum of 2 quarters · filed 2026-02-26 | $67.92M derived: sum of 3 quarters · filed 2026-02-26 | $91.30M 10-K · filed 2026-02-26 | |||
| 2024-09-27 | $20.49M 10-Q · filed 2025-11-06 | $43.97M derived: sum of 2 quarters · filed 2025-11-06 | $67.35M 10-Q · filed 2025-11-06 | $85.67M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-28 | $23.48M 10-Q · filed 2025-08-07 | $46.86M 10-Q · filed 2025-08-07 | $65.17M derived: sum of 3 quarters · filed 2026-02-26 | $85.08M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-29 | $23.38M 10-Q · filed 2025-05-08 | $41.70M derived: sum of 2 quarters · filed 2026-02-26 | $61.60M derived: sum of 3 quarters · filed 2026-02-26 | $80.52M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $18.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $38.22M derived: sum of 2 quarters · filed 2026-02-26 | $57.14M derived: sum of 3 quarters · filed 2026-02-26 | $75.33M 10-K · filed 2026-02-26 | |||
| 2023-09-29 | $19.90M 10-Q · filed 2024-11-06 | $38.82M derived: sum of 2 quarters · filed 2024-11-06 | $57.01M 10-Q · filed 2024-11-06 | $71.74M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-06-30 | $18.92M 10-Q · filed 2024-08-07 | $37.11M 10-Q · filed 2024-08-07 | $51.84M derived: sum of 3 quarters · filed 2025-02-26 | $67.44M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | $18.19M 10-Q · filed 2024-05-02 | $32.92M derived: sum of 2 quarters · filed 2025-02-26 | $48.52M derived: sum of 3 quarters · filed 2025-02-26 | $64.18M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | $14.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $30.32M derived: sum of 2 quarters · filed 2025-02-26 | $45.98M derived: sum of 3 quarters · filed 2025-02-26 | $60.83M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $15.60M 10-Q · filed 2023-11-07 | $31.26M derived: sum of 2 quarters · filed 2023-11-07 | $46.10M 10-Q · filed 2023-11-07 | $61.34M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-07-01 | $15.66M 10-Q · filed 2023-08-03 | $30.50M 10-Q · filed 2023-08-03 | $45.74M derived: sum of 3 quarters · filed 2024-02-22 | $58.20M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-04-01 | $14.84M 10-Q · filed 2023-05-04 | $24.40M 10-Q · filed 2022-05-10 | $30.08M derived: sum of 2 quarters · filed 2024-02-22 | $42.53M derived: sum of 3 quarters · filed 2024-02-22 | $53.57M derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2021-12-31 | $15.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $27.69M derived: sum of 2 quarters · filed 2024-02-22 | $38.73M derived: sum of 3 quarters · filed 2024-02-22 | $49.09M 10-K · filed 2024-02-22 | |||
| 2021-10-01 | $12.46M 10-Q · filed 2022-11-02 | $20.20M 10-Q · filed 2021-11-04 | $23.50M derived: sum of 2 quarters · filed 2022-11-02 | $33.86M 10-Q · filed 2022-11-02 | $61.40M 10-Q · filed 2021-11-04 | $28.27M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-07-02 | $11.04M 10-Q · filed 2022-08-04 | $21.30M 10-Q · filed 2021-07-28 | $21.40M 10-Q · filed 2022-08-04 | $41.20M 10-Q · filed 2021-07-28 | $15.81M derived: sum of 3 quarters · filed 2023-03-01 | $32.61M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-04-02 | $19.90M 10-Q · filed 2022-05-10 | $4.77M derived: sum of 2 quarters · filed 2023-03-01 | $21.57M derived: sum of 3 quarters · filed 2023-03-01 | $35.67M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | -$15.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.67M derived: sum of 2 quarters · filed 2023-03-01 | $15.77M derived: sum of 3 quarters · filed 2023-03-01 | $34.27M 10-K · filed 2023-03-01 | |||
| 2020-10-02 | $16.80M 10-Q · filed 2021-11-04 | $30.90M derived: sum of 2 quarters · filed 2021-11-04 | $49.40M 10-Q · filed 2021-11-04 | ||||
| 2020-07-03 | $14.10M 10-Q · filed 2021-07-28 | $32.60M 10-Q · filed 2021-07-28 | $17.20M 10-Q · filed 2020-08-06 | ||||
| 2020-04-03 | $18.50M 10-Q · filed 2021-04-29 | ||||||
| 2019-09-27 | $16.30M 10-Q · filed 2020-10-29 | $48.90M derived: sum of 2 quarters · filed 2020-10-29 | $44.80M 10-Q · filed 2020-10-29 | ||||
| 2019-06-28 | $32.60M 10-Q · filed 2020-08-06 | $28.50M 10-Q · filed 2020-08-06 | |||||
| 2011-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $2.61M derived: sum of 2 quarters · filed 2012-02-23 | $4.10M derived: sum of 3 quarters · filed 2012-02-23 | $5.71M 10-K · filed 2012-02-23 | |||
| 2011-09-30 | $1.44M 10-Q · filed 2011-10-27 | $2.93M derived: sum of 2 quarters · filed 2011-10-27 | $4.54M 10-Q · filed 2011-10-27 | $6.01M derived: sum of 4 quarters · filed 2012-02-23 | |||
| 2011-07-01 | $1.49M 10-Q · filed 2011-07-29 | $3.10M 10-Q · filed 2011-07-29 | $4.58M derived: sum of 3 quarters · filed 2012-02-23 | $6.16M derived: sum of 4 quarters · filed 2012-02-23 | |||
| 2011-04-01 | $1.61M derived: 10-K 12 month − 3 quarters · filed 2012-02-23 | $3.08M derived: sum of 2 quarters · filed 2012-02-23 | $4.67M derived: sum of 3 quarters · filed 2012-02-23 | $6.18M derived: sum of 4 quarters · filed 2012-02-23 | |||
| 2010-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $3.06M derived: sum of 2 quarters · filed 2012-02-23 | $4.58M derived: sum of 3 quarters · filed 2012-02-23 | $6.21M 10-K · filed 2012-02-23 | |||
| 2010-10-01 | $1.58M 10-Q · filed 2011-10-27 | $3.10M derived: sum of 2 quarters · filed 2011-10-27 | $4.73M 10-Q · filed 2011-10-27 | ||||
| 2010-07-02 | $1.52M 10-Q · filed 2011-07-29 | $3.15M 10-Q · filed 2011-07-29 | |||||
| 2009-12-31 | $5.93M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |